Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [18F]fluorocholine PET/CT
Positron emission tomography (PET) using the radiopharmaceutical tracer fluorine-18 fluorocholine (FCh) can elucidate tumors based on differences in choline phospholipid metabolism between tumor and surrounding tissue. The feasibility of detecting hepatocellular carcinoma (HCC) using FCh PET has bee...
Main Authors: | Sandi A. Kwee, Linda L. Wong, Brenda Y. Hernandez, Owen T.M. Chan, Miles M. Sato, Naoky Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-05-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4418/5/2/189 |
Similar Items
-
The Pharmacokinetics of F-18 Fluorocholine in Detecting Breast Cancer Patients
by: Shazreen Shaharuddin, et al.
Published: (2020-11-01) -
A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis
by: Kalevi Kairemo, et al.
Published: (2021-12-01) -
Occult prostate cancer detected with 18F-fluorocholine positron emission tomography/computed tomography
by: Wanying Xie, et al.
Published: (2014-01-01) -
Misleading localization by 18F-fluorocholine PET/CT in familial hypocalciuric hypercalcemia type-3: a case report
by: Noha N Mukhtar, et al.
Published: (2021-01-01) -
Dual-stage 18F-fluorocholine PET/CT scanning for biochemical recurrences of prostate cancer
by: M. B. Dolgushin, et al.
Published: (2015-06-01)